Beyond Breasts: Women’s Health, HRT, and a New Era of Care

Beyond Breasts: Women’s Health, HRT, and a New Era of Care

For more than two decades, women’s health conversations have been dominated—often distorted—by fear. Fear of hormones due to fear of breast cancer. Fear of asking for support during perimenopause and menopause. And fear of being dismissed.

But women’s health is more than breasts alone. We are whole-body systems. Hormonal changes influence our bones, hearts, brains, muscles, joints, urinary tracts, and metabolic health. When hormones decline during perimenopause and menopause, those changes are real, measurable, and often life-altering.

As the FDA updates warnings on certain estrogen products, we are entering a long-overdue shift toward individualized, informed decision-making—not exaggeration or dismissal, but honest discussion of both risks and benefits.

This new era recognizes a fundamental truth: women’s health goes beyond breasts.

A History of Narrow Focus: When Women’s Health Meant Reproduction

For much of modern medicine, women’s health was defined almost exclusively by reproductive function. Pregnancy, birth control, and fertility received attention—while heart disease, bone health, pain syndromes, and aging were treated as afterthoughts.

Compounding the problem, women were largely excluded from clinical trials until 1993. Medications were tested on male bodies and extrapolated to women, despite profound physiological differences.

As a result:

• Cardiovascular disease in women was underrecognized

• Autoimmune and chronic pain conditions were poorly studied

• Menopause received little serious research

• Long-term hormone loss was viewed as benign

Early results of the Women’s Health Initiative released in 2002 were largely misrepresented and distorted—leading to widespread fear and a dramatic drop in hormone therapy use.

The result?
Twenty years of women suffering avoidable symptoms—and avoidable disease risks—without access to balanced information.

And a whole generation of medical providers who don’t know how to support women in menopause adequately. Most don’t even know how to prescribe hormones, especially the modern, bio-identical formulations (estradiol and progesterone), different from those studied in the WHI.

Clinical Perspective

In the years following the initial Women’s Health Initiative release, many clinicians found themselves deeply confused. What the headlines reported did not match what was unfolding in exam rooms. Providers who had long prescribed hormone therapy were not witnessing sudden spikes in breast cancer or catastrophic outcomes among their patients—yet fear spread rapidly. Hormone prescriptions plummeted, and in their place came a sharp rise in antidepressants and sleep aids, which have since become first-line treatments for many menopause-related symptoms despite doing nothing to address hormonal loss itself.

Anecdotally, in 14 years working as an HRT nurse, the number of breast cancer diagnoses among our patients is less than the national average (1 in 8). Far more common are the stories of women who had seen multiple providers—seeking relief, information, or simply to be heard—only to be dismissed, shamed, or told their symptoms were “normal” and they should just endure them. For years, many of our patients didn’t feel safe disclosing to other providers that they were using hormone therapy at all. That silence speaks volumes about the culture of fear that replaced clinical nuance—and the cost women have paid for it. On the flipside, I’ve also seen firsthand how access to thoughtful menopause care can change the trajectory of aging, with many women entering this stage stronger, more resilient, and more vibrant than they ever expected.

The Cost of Two Decades of Fear

The widespread withdrawal from hormone therapy after the WHI didn’t just change prescriptions — it reshaped the entire landscape of women’s midlife care.

Millions of women endured symptoms like:

• Debilitating hot flashes
• Sleep disruption
• Mood instability
• Cognitive fog
• Vaginal dryness and pain
• Urinary issues
• Accelerated bone loss
• Muscle and joint pain
• Changes in cardiovascular and metabolic health, including rising cholesterol and weight gain

But many were told these were just “normal signs of aging” or “something to tough out.”

The breast cancer fear overshadowed everything else.
The assumption that estrogen is inherently dangerous went unchallenged.
Women’s health was once again confined to a single body part — even though menopause affects every system.

The FDA’s Recent Changes: A Step Toward Balance

Recently, the FDA removed black box warnings from certain estrogen products, acknowledging that:

• Earlier warnings were based on limited, often misinterpreted data
• Timing, dose, and delivery method significantly affect outcomes
• Not all estrogen therapies carry the same risk profile.
• Many women’s symptom relief and long-term benefits were overshadowed by fear-based communication
• Women deserve current, accurate information to guide their decisions

This shift does not claim estrogen is risk-free. Instead, it acknowledges that blanket warnings oversimplified women’s health—and prevented meaningful conversations between patients and providers.

Women’s Health Beyond Breasts: Estrogen’s Role Across Body Systems

Estrogen is not just a “reproductive” hormone. It is a regulatory hormone that influences nearly every system in a woman’s body.  Menopause is a major hormonal transition with whole-body effects. When the medical world fixates solely on breast cancer fear, the broader health landscape disappears.

Let’s bring it back into focus. Here’s what decades of research now show—

Bone Health & Osteoporosis Prevention

Estrogen is one of the strongest natural protectors of bone density.

• After menopause, women can lose up to 20% of their bone density within the first 5–7 years.
• HRT has consistently been shown to reduce fracture risk by 20–40%, depending on dose, duration, and delivery method.
• Hip fractures carry serious risk: nearly 1 in 5 women dies within a year of a hip fracture due to complications, immobility, or secondary illness.

For many women, hormone therapy is considered first-line therapy for osteoporosis prevention.

Heart Health & Cardiovascular Risk

Heart disease is the #1 killer of women, not breast cancer.

Before menopause, women’s estrogen provides natural cardiovascular protection through:

• Improved lipid profiles
• Reduced arterial stiffness
• Better vascular function

Without estrogen, cardiovascular risk accelerates.

Evidence shows:

• When started in early menopause, HRT is associated with a 30–50% reduction in coronary artery disease risk and may lower cardiovascular and all-cause mortality in some populations.
• Late initiation (well beyond menopause onset) doesn’t seem to offer these benefits based on current research.

Brain Health & Cognitive Support

Estrogen plays a major role in:

• Synaptic repair
• Glucose metabolism in the brain
• Cerebral blood flow
• Memory and executive function

Research shows:

• Women make up two-thirds of Alzheimer’s disease cases, likely due in part to the steep decline in estrogen.
• Early menopause (before 45) without hormone support is associated with a 30–70% increased risk of cognitive decline, depending on the study.
• Some research suggests HRT started at the right time may reduce dementia risk, though evidence is still evolving and not yet definitive.

We can’t say estrogen prevents dementia, but estrogen is clearly relevant to brain aging and deserves to be part of the conversation.

Metabolism, Weight, and Glucose Regulation

Estrogen affects:

• Insulin sensitivity
• Fat distribution (towards visceral/central fat)
• Mitochondrial function
• Inflammatory pathways

After menopause:

• Risk of metabolic syndrome increases by ~60% within 10 years.
• HRT has been shown in several studies to reduce central weight gain and improve insulin sensitivity.

These shifts matter for long-term health and quality of life.

Emotional and Sleep Health

Estrogen influences:

• Serotonin
• Dopamine
• GABA receptors
• Sleep regulation

Women in perimenopause have:

• 2–4× higher risk of developing new-onset depression
• Sleep disturbances that can persist for years

HRT may help reduce these symptoms and restore quality of life.

Urogenital & Sexual Health: The Overlooked Core of Women’s Well-Being

One of the most neglected areas of women’s health is urogenital and sexual health. Many women assume urinary urgency, incontinence, pain with intercourse, or chronic UTIs are “just aging.” In reality, these symptoms reflect Genitourinary Syndrome of Menopause (GSM)—a highly treatable condition affecting 50–70% of postmenopausal women.

Estrogen loss leads to:

• Vaginal dryness and pain

• Higher vaginal pH

• Thinning of vulvar and urethral tissue

• Increased urinary urgency

• Increased UTI risk

Vaginal estrogen—one of the safest, most effective menopause therapies—has been shown to:

• Reduce recurrent UTIs by 50–75%

• Approximately 80–90% of women experience meaningful improvement in lubrication, elasticity, comfort with intercourse and overall sexual satisfaction.

• Decrease urinary urgency and irritation

Minimal Systemic Risk

Vaginal estrogen:

• Can be started at any age
• Has never been shown to cause cancer or any kind of blood clots
• Is appropriate for long-term use
• Is appropriate for women who cannot use systemic HRT
• Current guidelines permit use for breast cancer survivors

Urogenital health is whole-body health—affecting sleep, confidence, intimacy, infection risk, and daily comfort.

Musculoskeletal Syndrome of Menopause

Up to 70% of women experience new or worsening musculoskeletal symptoms during the menopause transition, including:

• Joint pain and morning stiffness
• Muscle soreness
• Tendon sensitivity
• Increased risk of frozen shoulder
• Flare-ups of osteoarthritis

Estrogen plays a key role in:

• Collagen maintenance
• Tendon elasticity
• Muscle repair
• Inflammatory signaling

When estrogen declines, these tissues lose support—leading to discomfort many women assume is “just aging.”
HRT has been shown in some studies to reduce joint pain, improve stiffness, and support muscle maintenance, especially when combined with exercise.

Thermography’s Advantage: Assessing Estrogen’s Effects on Breast Tissue

Thermography as an added screening can help visualize physiological patterns—vascular changes, inflammation, and heat signatures—that may correlate with estrogen stimulation in breast tissue.

For women who want tools to help them understand how their bodies respond to hormones — whether naturally, in perimenopause, or through treatment, thermography may offer:

• A non-invasive way to observe how breast tissue responds over time
• Additional context for risk-reduction strategies
• Insight into inflammation that can be addressed proactively

Thermography provides a valuable functional perspective, helping women and clinicians observe physiological changes in real time, becoming part of a broader, more personalized picture of breast and whole-body health.

A New Era of Women’s Health

For decades, women were excluded from research, overwhelmed by fear-based messaging, and denied nuance in care.

Today, we are moving toward a model built on:

• Evidence

• Choice

• Whole-body health

• Shared decision-making

Turns out, “When you give women information about how their bodies work, they make great decisions for themselves.” —Rachel Rubin MD